| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INZY | Common Stock | Options Exercise | +25,000 | +101% | 49,865 | 01 Apr 2025 | Direct | F1, F2 | ||
| transaction | INZY | Common Stock | Sale | $7,849 | -8,819 | -18% | $0.8900 | 41,046 | 02 Apr 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INZY | Restricted Stock Units | Options Exercise | $0 | -25,000 | -33% | $0.000000 | 50,000 | 01 Apr 2025 | Common Stock | 25,000 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. |
| F2 | Includes 2,490 shares of common stock acquired under the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan on March 31, 2025. |
| F3 | This transaction was effected pursuant to a durable automatic sale instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the reporting person. |
| F4 | On April 1, 2023, the reporting person was granted 100,000 RSUs. Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in equal annual installments on each anniversary of the grant date until the fourth anniversary of the grant date. |